Lynk Pharmaceuticals Announces NMPA Acceptance of New Drug Application for Zemprocitinib in the Treatment of Rheumatoid Arthritis

MThe Miami Times·By By Lynk Pharmaceuticals Co., Ltd.·November 6, 2026 Read on The Miami Times ↗

0 sent to miamitimesonline.com154 headlines carried

SHANGHAI and HANGZHOU, China and BOSTON, Nov. , Ltd

The full story is at The Miami Times.

The Miami Times reported this story. TUEPAC carries the headline and opening so you can find it here; the reporting, photos, and readership stay with the publisher.

Continue at miamitimesonline.com ↗Opens the publisher's site

Stay on this

Follow what you care about and we send a weekly digest, every story linked to its publisher.

More from The Miami TimesAll headlines →

Millions Of Americans Have Prediabetes; What Older Adults Need To Know

10H

Septic Tank Pumping Kingston releases homeowner guide to City of Kingston septic permits, inspections and pumping, as updated Ontario Building Code rules for septic systems remain in effect

13H

Peptide Nerds Went Looking for the Best GLP-1 Providers. Then They Found the Fine Print.

13H

Headline and an excerpt of at most 40 words from the publisher's public feed. This page's canonical URL points to the original at miamitimesonline.com. How we carry publishers' work · Publisher: see your report